Genespire Revenue and Competitors
Estimated Revenue & Valuation
- Genespire's estimated annual revenue is currently $2.6M per year.
- Genespire's estimated revenue per employee is $155,000
- Genespire's total funding is $69M.
Employee Data
- Genespire has 17 Employees.
- Genespire grew their employee count by 13% last year.
Genespire's People
| Name | Title | Email/Phone |
|---|
Genespire Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Genespire?
Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases. Based in Milan, Italy, Genespire was founded in March 2020 by the gene therapy pioneer Prof. Luigi Naldini, Dr. Alessio Cantore, Fondazione Telethon and Ospedale San Raffaele. It is a spin-off of SR-Tiget, a world leading cell and gene therapy research institute and is backed by Sofinnova Partners.
keywords:N/A$69M
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 17 | -11% | N/A |
#2 | $1.1M | 17 | 6% | $4.4M |
#3 | $1.5M | 17 | N/A | N/A |
#4 | $3.1M | 17 | N/A | N/A |
#5 | $2.1M | 17 | N/A | N/A |
